ENA 2026 Exhibitors
Nov 18–20, 2026 Barcelona, Spain ~1.5k attendees Website
16 organizations exhibit at ENA 2026 — 12 CROs and suppliers, 2 agencies, groups and societies and 2 drug developers. 10 of them also present on the scientific program, with 25 presentations between them. Most represented: Crown Bioscience, Biocytogen and European Organisation for Research and Treatment of Cancer (EORTC). As of Oct 13, 2026.
Topic
Top represented
Showing 1–16 of 16 organizations
| Organization | ENA 2026 Attendance |
|---|---|
Crown Bioscience San Diego, CA | |
Preclinical oncology CRO offering patient-derived xenograft, organoid and syngeneic models plus translational and biomarker services. | Booth Exhibiting at Booth 30 Wed, Nov 1812–7pmThu, Nov 199am–5:30pmFri, Nov 209am–3pm Poster Wed Nov 18 12–1:30pm 3:50–4:15pm 5:45–7pm Poster Thu Nov 19 9:30–10am 1–3pm 4:30–5pm Poster Fri Nov 20 10:45–11:15am 1:30–3pm Poster Fri Nov 20 10:45–11:15am 1:30–3pm Poster Fri Nov 20 10:45–11:15am 1:30–3pm Poster Fri Nov 20 10:45–11:15am 1:30–3pm Poster Fri Nov 20 10:45–11:15am 1:30–3pm |
Biocytogen Beijing, China | |
Provides humanized mouse models, preclinical pharmacology and antibody discovery, and develops its own antibody and ADC candidates. | Booth Exhibiting at Booth 23 Wed, Nov 1812–7pmThu, Nov 199am–5:30pmFri, Nov 209am–3pm Poster Wed Nov 18 12–1:30pm 3:50–4:15pm 5:45–7pm Poster Thu Nov 19 9:30–10am 1–3pm 4:30–5pm Poster Fri Nov 20 10:45–11:15am 1:30–3pm Poster Fri Nov 20 10:45–11:15am 1:30–3pm |
European Organisation for Research and Treatment of Cancer (EORTC) Brussels, Belgium | |
Non-profit that runs multinational academic cancer clinical trials and co-organizes this symposium. | Booth Exhibiting at Booth 17–20 Wed, Nov 1812–7pmThu, Nov 199am–5:30pmFri, Nov 209am–3pm Session Wed Nov 18 10am–12pm Talk Wed Nov 18 10–10:10am Talk Wed Nov 18 10:10–10:25am |
WuXi AppTec Shanghai, China | |
Contract research, development and manufacturing organization offering drug discovery, in vivo pharmacology, testing and manufacturing services. | Booth Exhibiting at Booth 9 Wed, Nov 1812–7pmThu, Nov 199am–5:30pmFri, Nov 209am–3pm Poster Wed Nov 18 12–1:30pm 3:50–4:15pm 5:45–7pm Poster Wed Nov 18 12–1:30pm 3:50–4:15pm 5:45–7pm |
ICE Bioscience Beijing, China | |
Contract research organization offering target validation, compound screening and preclinical drug discovery services. | Booth Exhibiting at Booth 10 Wed, Nov 1812–7pmThu, Nov 199am–5:30pmFri, Nov 209am–3pm Poster Wed Nov 18 12–1:30pm 3:50–4:15pm 5:45–7pm Poster Thu Nov 19 9:30–10am 1–3pm 4:30–5pm Poster Thu Nov 19 9:30–10am 1–3pm 4:30–5pm |
XenTech Évry, France | |
Preclinical contract research company specialising in patient-derived xenograft models, including models of acquired resistance to targeted therapies. | Booth Exhibiting at Booth 8 Wed, Nov 1812–7pmThu, Nov 199am–5:30pmFri, Nov 209am–3pm Poster Fri Nov 20 10:45–11:15am 1:30–3pm Poster Fri Nov 20 10:45–11:15am 1:30–3pm |
Kyinno Beijing, China | |
Preclinical contract research organization offering in vitro and in vivo pharmacology, cell line engineering and antibody discovery. | Booth Exhibiting at Booth 31 Wed, Nov 1812–7pmThu, Nov 199am–5:30pmFri, Nov 209am–3pm Poster Fri Nov 20 10:45–11:15am 1:30–3pm |
Pfizer New York, New York | |
Global pharmaceutical company whose oncology portfolio includes antibody-drug conjugates gained with Seagen. | Booth Exhibiting at Booth 26 Wed, Nov 1812–7pmThu, Nov 199am–5:30pmFri, Nov 209am–3pm |
Reaction Biology Malvern, PA | |
Contract research company offering biochemical, cell-based and in vivo pharmacology services for drug discovery, including kinase profiling. | Booth Exhibiting at Booth 7 Wed, Nov 1812–7pmThu, Nov 199am–5:30pmFri, Nov 209am–3pm Poster Wed Nov 18 12–1:30pm 3:50–4:15pm 5:45–7pm |
Turbine Budapest, Hungary | |
Builds AI-based simulated cell models that predict drug response, resistance and combinations for oncology drug discovery. | Booth Exhibiting at Booth 27 Wed, Nov 1812–7pmThu, Nov 199am–5:30pmFri, Nov 209am–3pm Poster Fri Nov 20 10:45–11:15am 1:30–3pm |
American Association for Cancer Research (AACR) Philadelphia, PA | |
Professional society for cancer research that publishes journals, holds scientific meetings and co-organizes this symposium. | Booth Exhibiting at Booth 5–6 Wed, Nov 1812–7pmThu, Nov 199am–5:30pmFri, Nov 209am–3pm |
Champions Oncology Hackensack, NJ | |
Oncology research services company offering patient-derived xenograft models, ex vivo testing and translational data. | Booth Exhibiting at Booth 25 Wed, Nov 1812–7pmThu, Nov 199am–5:30pmFri, Nov 209am–3pm |
Foundation Medicine Boston, MA | |
Genomic profiling company offering tissue and liquid biopsy tests and companion diagnostics; part of Roche. | Booth Exhibiting at Booth 4 Wed, Nov 1812–7pmThu, Nov 199am–5:30pmFri, Nov 209am–3pm |
FUJIFILM Wako Pure Chemical Osaka, Japan | |
Maker of laboratory reagents and chemicals, including cell culture and assay products; part of FUJIFILM. | Booth Exhibiting at Booth 21 Wed, Nov 1812–7pmThu, Nov 199am–5:30pmFri, Nov 209am–3pm |
Revolution Medicines Redwood City, CA | |
Clinical-stage oncology company developing RAS(ON) inhibitors, including daraxonrasib, for RAS-addicted cancers. | Booth Exhibiting at Booth 28 Wed, Nov 1812–7pmThu, Nov 199am–5:30pmFri, Nov 209am–3pm |
Software for planning, running and recording preclinical animal studies, including tumor measurements and dosing. | Booth Exhibiting at Booth 32 Wed, Nov 1812–7pmThu, Nov 199am–5:30pmFri, Nov 209am–3pm |
Instantly find 20 buyers from ENA 2026 exhibitors
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Browse ENA 2026 by
Organization type
Topic
- Molecular targeted agents, combinations and drug resistance 98
- Antibody–drug conjugates and radiopharmaceuticals 39
- Immunotherapy, immune engagers and the tumour microenvironment 34
- Cell therapies (CAR-T, TCR) 6
- Drug design and delivery, degraders and new agents 45
- Cancer genomics, molecular profiling and precision oncology 26
- Biomarker assays and translational studies 24
- Preclinical and animal models and drug screening 23
- Early clinical development, trial design and toxicity 22
- Artificial intelligence in cancer drug development 6
Exhibit hall
- Exhibitors 16
Everyone
Not affiliated with or endorsed by EORTC, the NCI or the AACR. Submit a correction